Argentina sets out rules for switching from prescription to OTC status
This article was originally published in SRA
Executive Summary
ANMAT, Argentina's drug and healthcare products regulatory agency, has issued a regulation establishing the minimum requirements that companies need to follow in order to switch their product from prescription-only to over-the-counter status1.